Why the study?
Does ongoing low-dose aspirin treatment increase bleeding complications in patients undergoing cervical laminoplasty?
Does ongoing low-dose aspirin treatment increase bleeding complications in patients undergoing cervical laminoplasty?
Continuing low-dose aspirin during cervical laminoplasty appears safe, as it does not significantly increase bleeding complications or the risk of symptomatic epidural hematoma.
Supports continuing low-dose aspirin in cervical laminoplasty without excess bleeding; hypothesis-generating and requires randomized confirmation.
Purpose : Antiplatelet drugs reduce the risk of ischemic events but increase the risk of bleeding. A decision to discontinue these drugs can be made only after weighing the risk of bleeding against the risk of thromboembolic ischemic events. Here, we report two cases of cerebral infarctions in patients who underwent cervical and lumbar surgeries after discontinuation of low-dose aspirin treatment during the period starting in October 2006. Because of these events, we abandoned practice of suspending low-dose aspirin treatment perioperatively in all cases of spinal surgery. Since April 2010, all spinal surgeries have been carried out without discontinuing low-dose aspirin. Here, we report the safety of ongoing low-dose aspirin treatments in patients undergoing cervical laminoplasty.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: